Evaluating the Safety and Efficacy of Qishen Granules Among Patients With Chronic Heart Failure

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT03027375

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03027375
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03027375. Randomized; triple masking; primary purpose treatment. Start 2017-03-31 (actual); primary completion 2018-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluating the Safety and Efficacy of Qishen Granules Among Patients With Chronic Heart Failure
Condition
Heart Failure
Condition
Cardiovascular Diseases
Intervention (Drug)
Qishen Granules
Intervention (Drug)
Placebo
Lead sponsor
Beijing University of Chinese Medicine (class: other)
Collaborator
China-Japan Friendship Hospital (class: other)
Collaborator
Zhengzhou Hospital of Traditional Chinese Medicine (class: other)
Collaborator
Beijing Anzhen Hospital (class: other)

Record details

Record id
cardio:ct-nct03027375
Content hash
08580729ed63ff5fa7a7046f48796aff72f6c6584e9ee479bf80006d5499dfeb